*	OR T1 T2 T5
R1	Has_negation Arg1:T3 Arg2:T4	
R2	Has_value Arg1:T6 Arg2:T7	
R3	Has_multiplier Arg1:T9 Arg2:T8	
R4	Has_value Arg1:T10 Arg2:T11	
R5	Has_value Arg1:T12 Arg2:T13	
R6	Has_value Arg1:T14 Arg2:T15	
R7	Has_value Arg1:T16 Arg2:T17	
R8	Has_value Arg1:T18 Arg2:T19	
R9	Has_value Arg1:T20 Arg2:T21	
R10	Has_value Arg1:T22 Arg2:T23	
R11	Has_value Arg1:T24 Arg2:T25	
R12	Has_value Arg1:T26 Arg2:T27	
R13	Has_value Arg1:T28 Arg2:T29	
R14	Subsumes Arg1:T28 Arg2:T30	
R15	Has_value Arg1:T32 Arg2:T33	
T1	Condition 0 13	Primary B-NHL
T2	Condition 15 19	PTCL
T3	Condition 21 101	ALK+ anaplastic large cell lymphoma and NK(natural killer cell )/T cell lymphoma
T4	Negation 107 115	excluded
T5	Condition 120 122	HL
T6	Person 162 166	Ages
T7	Value 167 196	=18 years old, < 80 years old
T8	Multiplier 252 264	At least one
T9	Condition 276 282	lesion
T10	Observation 285 308	Expected survival time=
T11	Value 308 316	3 months
T12	Measurement 335 347	transaminase
T13	Value 347 380	=2.5× upper limit of normal value
T14	Measurement 381 390	bilirubin
T15	Value 390 422	=1.5×upper limit of normal value
T16	Measurement 441 457	serum creatinine
T17	Value 461 474	44-133 mmol/L
T18	Measurement 491 499	test:WBC
T19	Value 499 509	=3.0×109/L
T20	Measurement 510 521	Neutrophils
T21	Value 521 531	=1.5×109/L
T22	Measurement 532 534	Hb
T23	Value 534 541	=100g/L
T24	Measurement 542 550	Platelet
T25	Value 550 559	=80×109/L
T26	Measurement 561 565	LVEF
T27	Value 565 569	=50%
T28	Measurement 572 598;606 635	New York Heart Association heart function classification
T29	Value 639 649	I-II grade
T30	Measurement 600 604	NYHA
T31	Informed_consent 651 674	signed informed consent
T32	Measurement 199 245	ECOG (Eastern Cooperative Oncology Group)score
T33	Value 247 250	0-2
